The International Society on Thrombosis and Haemostasis is an inclusive network of scientists dedicated to research, education and improvement of the lives of those who suffer with diseases and disorders of thrombosis, hemostasis and their underlying vascular biology. You are welcome to join ISTH by application and payment of annual membership dues.

Membership is individual and is not transferable. Categories of membership are:

Regular  $160/year

Associate $35/year

Applications are accepted throughout the year and are not pro-rated.

For online enrollment, please visit You may also email or telephone the Membership Secretary, Sharon Overcash, at and + 1 919 929 3807.

Pier M Mannucci Awards

Prizes will be awarded to young investigators who publish articles in the Journal of Thrombosis and Haemostasis in 2012.

The awards have been named in honour of Prof. P.M. Mannucci, the first Editor in Chief of JTH, and are made possible by a generous contribution from Bayer HealthCare. Recipients are selected by a jury of editors. Proof of age is required. Please contact for more information.

ISTH Visiting Professor Program

ISTH announces a new program targeted to Thrombosis and Hemostasis Centers in underprivileged countries. The program provides for an expert visiting professor who will offer an intensive course on a selected issue, or a series of lectures on selected topics, as agreed with the host center. The duration of the visit is four to seven days, and ISTH covers airfare, accommodation and living expenses for the Visiting Professor.

Applications and details are available from the ISTH homepage,, at the Program Announcement. For more information, contact ISTH headquarters by email (

ISTH Advanced Fellowships for young colleagues from underprivileged countries

ISTH announces a new program targeted to advanced Fellows from underprivileged countries who wish to pursue knowledge and expertise in one or all of the following areas: medical care, laboratory methods, or research related to thrombosis and hemostasis. Applicants should be 37 years old or younger. Fellowships will be up to a four month period, and will include economy class travel and housing. Applications will be approved on a competitive basis by the ISTH Educational committee.

Deadlines for submission of applications are 1 January and 1 June of each year, and can be found on the ISTH homepage,, at the Fellowship Announcement. For more information, contact ISTH headquarters by email (

Novo Nordisk Haemophilia Foundation (NNHF) website ( is activated

NNHF was created in 2005 as an independent, non-commercial organisation in Zurich, Switzerland, to address the significant need for improving haemophilia care and treatment in the developing world. NNHF works with partners in governments, NGOs and healthcare specialists in supporting development programmes, such as the education and training of patients, doctors, nurses and laboratory technicians, the improvement of disease diagnosis and the establishment of patient registries. NNHF also offers awards and fellowships. Contact at

2nd Maastricht School on Thrombin Generation

2–5 October, 2012, in Maastricht, the Netherlands. For the second time Maastricht will be the stage for the Maastricht School on Thrombin Generation. The meeting will be 4–day event held at the Cardiovascular Research Institute Maastricht (CARIM), Maastricht. The activities will comprise:

1) Lectures by experienced faculty

2) Hands on experience with different available techniques

3) Master-classes in which attendees have the opportunity to present their proper research before a panel from the faculty.

The number of attendees is restricted to 100 and the registration fee shall include lodging and meals. Candidates are invited to send an abstract of no more than 300 words on the work that they wish to present. The best three abstracts will be granted an award equal to the registration fee. Five stipends are available for young scientists from developing countries or severely financially restricted. Admittance is on quality of abstract. Registration deadline is 1 June 2012.

For more information please contact Dr Raed Al Dieri ( or Dr Bas de Laat (

44th Advances in Haematology Course

3–5 October, 2012, at Imperial College London, W12 Hammersmith Conference Centre, London, UK. Please join us at the 44th Advances in Haematology course at the Hammersmith Hospital in October 2012. The course has an enviable and long-standing international reputation as an independent educational event reviewing the most recent advances in the biology and management of blood disorders, benign and malignant, and is appreciated and recommended by trainees and established consultants. This year, in acknowledging the difficulties in obtaining prolonged study leave, we are introducing a new format, shortened to three days but maintaining high quality and comprehensive reviews delivered by an international faculty.

For further details & online registration, please visit

Minutes of the General Assembly of the International Society for Fibrinolysis and Proteolysis (ISFP) (Brighton, 3 July 2012)

Composition of the council

J. Wojta becomes chairman after the Brighton congress and J. Meijers remains as Secretary-Treasurer until 2014. P. Declerck was elected as new Chairman-Elect, to become Chairman in 2014. Class 2012 (L. Bajzar, P. Declerck, V. Ellis, J. Wojta) retires after this congress. Class 2014 (C. Kluft, F. Lupu, V. Ploplis) and Class 2016 (`D. Lawrence, T. Urano, M. Geiger, L. Miles) will continue. New Class 2018 members (M. Colucci, T. Lisman, N. Mutch and D. Vivien) were accepted by the General Assembly. R. Lijnen continues as Executive Director, and the ex-officio members (A. Gils, M. De Maat, R. Medcalf) are also prolonged.


Nine new regular membership and eight junior membership applications were accepted by the General Assembly; 88 full memberships were paid in 2011 and 22 junior memberships are registered. Ten complimentary memberships are prolonged for another year. A membership directory will be e-mailed to all members.

Financial situation

The income statement and balance 2011 and the proposed budget for 2012 were approved by the General Assembly. The membership fee for 2013 will be kept at 60 or 100 for 2013-2014. Two travel grants were awarded (to M. Sashindranath and E. Vercauteren).

The Council decided to continue the D. Collen Young Investigator Awards (1 x 5,000 $ and 4 x 1,000 $) and the ISFP Prize (10,000 $) at the next ISFP Congress.

Society Journal

The impact factor of JTH is now 5.74. The overall acceptance rate of manuscripts is 31%. As Associated Editor section Fibrinolysis, R. Medcalf suggests that ISFP members make suggestions for review topics and write commentaries on fibrinolysis-related papers. The term of R. Medcalf as Associate Editor is scheduled to end when the newly elected editors-in-chief (F. Rosendaal, P. Reitsma) will be in office. R Medcalf will however stay on during the transition of the new Editors until the end of 2013. Candidates (6 year term) for Associate Editor, section Fibrinolysis, should contact the Executive Director.

Congress 2014

The 2014 ISFP Congress will take place in Marseille, organized by M.-C. Alessi, P. Morange and F. Dignat-George. Tentatively it is scheduled in the first half of July. Because of the decreasing number of Abstracts submitted, it may be considered to reduce the duration of the Congress.


Candidates to organize the 2016 ISFP congress are solicited. A new, more dynamic, website was developed (

H.R. Lijnen

Executive Director

The 6th Annual Congress of The European Association for Haemophilia and Allied Disorders (EAHAD)

6–8 February 2013, in Warsaw, Poland. The EAHAD organizes a yearly congress throughout Europe. Pr. Jerzy Windyga, President of the Organizing Committee, and Pr. Jan Astermark, President of the EAHAD, welcome you for a unique opportunity for learning, teaching and socializing. More information, congress registration and abstract submission are available online at:

Invited speakers include: E. Berntorp, P. Collins, R. D’Oiron, P. A. Holme, P.M. Mannucci, S. Bjorkman, R. Ljung, R. Lassila, A. Coppola, A. Batorova, C. Kessler.

The European Association for Haemophilia and Allied Disorders (EAHAD) is a multi-disciplinary association of healthcare professionals who provide care for individuals with haemophilia and other bleeding disorders. Our purpose is to promote clinical care, education and research for this group of patients across the continent. You are welcome to join the EAHAD by application and payment of annual membership fees (